ZTO Express heads into its May 15 Q1 earnings report riding a quiet but genuine stock recovery — up 20% year-to-date and within reach of a price target that was just raised above where the stock now trades.
The most actionable analyst signal here is a recent JPMorgan move. In April, JPMorgan raised its ZTO target from $25 to $29, keeping an Overweight rating — a vote of confidence that comes at a moment when the stock at $25.01 is essentially at the prior target and still 16% below the new one. That upgrade anchors a broadly constructive Street view: analyst consensus implies roughly 15.6% return potential from current levels. B of A Securities holds a Neutral rating. With EPS surprise ranking in the 99th percentile of the ORTEX universe and forward EPS momentum in the 78th percentile over 90 days, the fundamental track record has given bulls reason to lean in — the company has almost never missed estimates. Annual revenue runs at $8.2 billion with net income near $1.5 billion. At 7.3x EV/EBITDA and a 12.4x trailing P/E, valuation remains undemanding for a dominant Chinese logistics franchise.
The short positioning landscape adds little drama to the setup. Short sellers pulled back sharply over the past month — shares short dropped nearly 18% — bringing the borrow pool demand down considerably. Cost to borrow is minimal at 0.54%, and availability is ample, with utilization running around 24%, well below its 52-week peak of 69%. That means the borrow market is relaxed: no squeeze pressure, no elevated cost for bears. The ORTEX short score of 54.5, essentially neutral, reflects this equilibrium. Short interest simply isn't telling a contrarian story here in either direction.
Options positioning carries the more interesting pre-earnings tension. The put/call ratio has climbed to 2.66, near its 52-week high of 2.68 and well above its 20-day average of 2.62 — though the z-score of 0.4 keeps this shy of outright alarm. What the elevated PCR does signal is that the options market has accumulated a significant protective overhang relative to bullish call exposure. That structure can be read as hedging by long holders rather than pure directional bearishness, particularly given the stock's gentle uptrend. Founder and Chairman/CEO Meisong Lai holds 27.7% of shares, while Alibaba holds a further 8.8% — concentrated ownership that limits float and keeps institutional flows meaningful when they move. JPMorgan Chase as an institution built a position worth roughly $10.9 million as of late April.
Thursday's print is therefore less about whether ZTO can beat — it almost always does — and more about whether management's volume guidance for the back half of 2026 justifies the stock holding above the previous $25 consensus target and working toward the newly raised $29 level.
See the live data behind this article on ORTEX.
Open ZTO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
